Cancer-associated adipocyte signaling enhances aggressiveness and points to FABP4 as a therapeutic target for peritoneal metastasis.
CAA-derived exosomal signaling promotes SRCC aggressiveness through FABP4-mediated fatty acid metabolic reprogramming, identifying FABP4 as a potential therapeutic target for peritoneal metastasis in colorectal SRCC.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: